Global Health Research at Regional Biocontainment Laboratory and Research Innovation Center
In 2007, Colorado State University opened a $30 million laboratory at the Judson M. Harper Research Complex on our Foothills Campus. The laboratory, funded by a grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The laboratory, called the Regional Biocontainment Laboratory, gives CSU the ability to look for treatments, vaccines and tests for some of the world’s most concerning infectious diseases.
In the spring of 2010, the university completed an addition to the laboratory, the Research Innovation Center. The innovative building is designed to bring businesses and disease experts and other biomedical scientists together to optimize collective creativity and research around product development.
The 72,000-square-foot, $53 million Research Innovation Center is a hybrid of business office space, university researcher offices and state-of-the-art bioscience laboratories, conceptualized to build university partnerships with CSU startup businesses and existing businesses. The facility will house efforts to develop, perfect, analyze and market vaccines, tests and treatments for a variety of diseases including those that infect and kill millions of people and animals around the world each year, such as West Nile virus, drug-resistant tuberculosis, yellow fever, dengue fever, hantavirus, plague and tularemia.
These research facilities add to an existing federal and university infectious disease effort centered on the Colorado State campus including research already underway at the federal Centers for Disease Control and Prevention's infectious disease program and the university's existing Bioenvironmental Hazards Research Building and theArthropod-borne and Infectious Diseases Laboratory.
The facility houses research into finding cures, tests and preventative measures for infectious diseases including West Nile virus, drug resistant tuberculosis, yellow fever, dengue and hantavirus.
Colorado State was selected to receive the grant to build the Regional Biocontainment Laboratory in large part because of the university's long history and proven track record of safe and innovative research in infectious diseases.
This 33,850-square-foot laboratory provides advanced research capacity and facilities to bring university researchers together with government, academia and industry scientists whose expertise to develop new vaccines, therapies and diagnostics for these pathogens to help people across the globe.
Since the Sept. 11, 2001, terrorist attacks and the subsequent use of anthrax as a terrorist weapon, NIAID has dramatically increased funding for research in infectious and emerging diseases. Colorado State's Regional Biocontainment Laboratory and Research Innovation Center will help fill these gaps.